Driven by Trust
About Us
Parambil builds trusted, high quality software with a specialty in medical record review. The team combines clinical and statistical expertise with state of the art technology to provide an unparalleled product experience.
Built by the Best
At Parambil, our team brings together a diverse group of legal and technology professionals committed to transforming how firms understand medical records.
why parambil
Unlike point solutions or manual service providers, Parambil is a cross-vertical, AI-native platform that adapts to the complexity and speed of today’s litigation landscape.
What Sets Us Apart
Accelerated Case Review
95% faster review via our proprietary timeline engine
Enterprise-Grade Security
Defense-grade security and compliance features
Elite, Cross-Disciplinary Team
Built by a team with backgrounds at McKinsey, Stanford Medicine, and Yale Medicine.
Proven at the Highest Levels
Used in landmark MDLs and bet-the-company litigation
Streamlining MDL Censuses: How Parambil Al is Revolutionizing Court-Mandated Data Collection in Mass Tort Litigation
The landscape of mass tort litigation is rapidly evolving, and one of the most significant changes we're witnessing is the increasing frequency of court-mandated censuses at the very beginning of Multi District Litigation (MDL) proceedings. What was once an occasional requirement has now become standard practice, fundamentally changing how legal teams must approach case preparation and data management.
Our Annual Security Review: Why SOC 2, HIPAA Compliance, and Penetration Testing Matter
As we complete our yearly SOC 2 audit and penetration testing, we wanted to take a moment to discuss our approach to security, why these measures matter, and how they protect the sensitive data you entrust to us. In today's threat landscape, robust cybersecurity isn't just a technical requirement—it's fundamental to maintaining the trust and confidentiality that forms the foundation of our client relationships.
Don't Let Complex Plaintiff Fact Sheets Sink Your GLP-1 Cases: How AI Can Transform Your Weight Loss Litigation Practice
The weight loss drug litigation landscape has exploded with cases involving GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro. But there's a critical bottleneck preventing many firms from capitalizing on this lucrative area: the overwhelming complexity of plaintiff fact sheets (PFS).
Contact us
Connect with us
You can also use the feedback form below to reach out to us directly through our website.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.